MedWatch

Demant launches new flagship product

Hearing aid giant Demant has new flagship product ready, which has been rumored to replace the success Oticon Opn. On Monday, the firm also announces new products in three of its other brands.

Photo: Jens Dresling

Danish hearing aid firm Demant announced on Monday that it is ready with a new flagship product, which will supplement and take over where the predecessor Oticon Opn left off. The latter has been a huge success, but was launched all the way back in 2016 with the Oticon Opn S follow-up in 2019.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Ambu credits MDR milestone to fastidiousness

All of Medtech firm Ambu’s products already live up to the new EU rules for medical devices, something the firm attributes to a good sense of how much effort living up to the new legislation would require.

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs